Brief: Nectar Lifesciences March-Quarter Consol Profit From Continuing Operations Falls
15/05/2024 10:40
May 15 (Reuters) - Nectar Lifesciences Ltd NECT.NS :
* NECTAR LIFESCIENCES MARCH-QUARTER CONSOL PROFIT FROM
CONTINUING
OPERATIONS 5.9 MILLION RUPEES VERSUS PROFIT 36.8 MILLION RUPEES
* NECTAR LIFESCIENCES MARCH-QUARTER CONSOL REVENUE FROM
OPERATIONS
4.4 BILLION RUPEES VERSUS 3.88 BILLION RUPEES
Source text for Eikon: ID:nBSE392nGx
Further company coverage: NECT.NS
((Reuters.Briefs@thomsonreuters.com;;))
Recent news on Nectar Lifesciences
See all newsBrief: Nectar Lifesciences To Acquire 100% Paid- Up Equity Share Capital Of Avensis Exports
Brief: Nectar Lifesciences Approves Buyback Of Shares Valued At 810 Million Rupees
India's Nectar Lifesciences jumps on plan to consider buyback of shares
Brief: Nectar Lifesciences Proposes Buyback Of Equity Shares
Brief: Nectar Lifesciences Says Secured Debt And Interest Owed By Co Fully Repaid And Settled With Banks